CLARUS THERAPEUTICS HOLDINGS, INC.: operating_expenses
| Value | {"amount": 44859000, "concept": "us-gaap:OperatingExpenses", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | CLARUS THERAPEUTICS HOLDINGS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/92803bcd-bbc1-4f57-84fb-26abc50f3360
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-092120 · Open the official SEC filing →Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001817944/operating-expenses/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/92803bcd-bbc1-4f57-84fb-26abc50f3360
History
- no predecessors — first report